Basilea Pharmaceutica Ltd. Logo
 
 
News and Media
 
 
Search
 ›› go!
 

Dermatology 2011

 
 
 

Alitretinoin

  • Aguayo-Leiva IR, Urrutia S, Jaén-Olasolo P. Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: Experience in 15 patients. Actas Dermo-Sifiliogr. 2011; 102(8): 616-622.
  • Agusti-Mejias A, Sánchez Carazo JL, Messeguer Badia F, Alegre De Miguel V. Oral alitretinoin: Specific therapy for severe chronic eczema of the hands refractory to corticosteroids. Med Cutanea Ibero-Lat-Am. 2011; 39(4): 197-201.
  • Araceli S-G, Enrique G, Jose Luis L-E, Almudena N. Severe chronic hand eczema treated with alitretinoin. J Am Acad Dermatol. 2011; 64(2): AB63.
  • Baliga M. Tumours of the skin: Why does it interest maxillofacial surgeons? Oral Oncol. 2011; 47: S126.
  • Barnstedt SE. Successful treatment of Darier disease with oral alitretinoin. Hautarzt. 2011; 1-3.
  • Brehmer F, Haenssle HA, Schön MP, Emmert S. Response of recalcitrant lichen planus to alitretinoin in 3 patients. J Am Acad Dermatol. 2011; 65(2): e58-e60.
  • Diepgen TL, Purwins S, Posthumus J, Kuessner D, Augustin M. Burden of disease in patients with severe chronic hand eczema in Germany. Value Health. 2011; 14(7): A504.
  • Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Exp Dermatol. 2011; 36(2): 149-154.
  • Emmert B, Hallier E, Schön MP, Emmert S. Disease management guidelines in dermatology - Implementation, potentials and limitations exemplified by the guidelines for the management of hand eczema. Hautarzt. 2011; 62(4): 308-314.
  • English J, Graham-Brown R, De Sica Chapman A, Alexandroff AB. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: Seven case studies. Clin Exp Dermatol. 2011; 36(SPEC.ISS. 1): 1-2.
  • English JSC, Wootton CI. Recent advances in the management of hand dermatitis: Does alitretinoin work? Clin Dermatol. 2011; 29(3): 273-277.
  • Gass S. 5 Questions ... on alitretinoin (Toctino®). Haut. 2011; 22(4): 194.
  • Gulliver W, Baker KA. Long-term efficacy of alitretinoin in 3 patients with chronic hand eczema. J Am Acad Dermatol. 2011; 64(2): AB60.
  • Kubica E, Ezzedine K, Lalanne N, Dartial Y, Taieb A, Milpied B. Oral alitretinoin in chronic refractory hand eczema: A "real life" case-series of 12 patients. Eur J Dermatol. 2011; 21(3): 454-456.
  • Meyer V, Goerge T, Luger TA, Beissert S. Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin. J Clin Aesthetic Dermatol. 2011; 4(4).
  • Mota R, Kislat A, Buenemann E, Gerber A, Meller S, Maares J, Homey B. Insights into the mechanism of action of alitretinoin in chronic hand eczema. Allergy Eur J Allergy Clin Immunol. 2011; 66: 106-107.
  • Pinter A, Pätzold S, Kaufmann R. Lichen planus of nails - Successful treatment with Alitretinoin. JDDG J German Soc Dermatol. 2011; 9(12): 1033-1034.
  • Rodgers M, Griffin S, Paulden M, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M. Alitretinoin for severe chronic hand eczema. A nice single technology appraisal. PharmacoEcon Ital Res Artic. 2011; 13(1): 9-20.
  • Rojo R, Fuertes A, Marquina A, Ferrando F. Classic Kaposi sarcoma treated with topic imiquimod: One case report and review. J Am Acad Dermatol. 2011; 64(2): AB71.
  • Ruzicka T. New perspectives in chronic inflammatory skin diseases: Renaissance of retinoid. Basic Clin Pharmacol Toxicol. 2011; 109: 14.
  • Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris. Case Rep Dermatol. 2011; 3(1): 85-88.
  • Schmitt-Hoffmann AH, Roos B, Sauer J, Brown T, Weidekamm E, Meyer I, Schleimer M, Maares J. Low levels of alitretinoin in seminal fluids after repeated oral doses in healthy men. Clin Exp Dermatol. 2011; 36(SUPPL. 2): 12-17.
  • Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Kovacs P, Stoeckel K, Maares J. Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid). Clin Exp Dermatol. 2011; 36(SUPPL. 2): 18-23.
  • Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Schoetzau A, Leese PT, Weidekamm E, Maares J. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate. Clin Exp Dermatol. 2011; 36(SUPPL. 2): 4-11.
  • Schmitt-Hoffmann AH, Roos B, Sauer J, Spickermann J, Maares J, Schoetzau A, Meyer I. Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. Clin Exp Dermatol. 2011; 36(SUPPL. 2): 24-28.
  • Schmitt-Hoffmann AH, Roos B, Sauer J, Spickermann J, Stoeckel K, Edwards D, van de Wetering J, Coenraads PJ, Maares J. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema. Clin Exp Dermatol. 2011; 36(SUPPL. 2): 29-34.
  • Scott-Lang V, Norris J, Hardie R, Green C, Gupta G, Morton C, Kemmett D. Alitretinoin: The Scottish experience. Br J Dermatol. 2011; 165: 47-48.
  • Shapiro S, Heremans A, Mays DA, Martin AL, Hernandez-Medina M, Lanes S. Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature. J Am Acad Dermatol. 2011; 65(6): 1194-1201.
  • Werchau S, Toberer F, Enk A, Helmbold P. Keratitis-ichthyosis-deafness syndrome: Response to alitretinoin and review of literature. Arch Dermatol. 2011; 147(8): 993-995. 
 

 

Info